Walker WG - Search Results

1

X-Chromosome-Linked miRNAs Regulate Sex Differences in Cardiac Physiology.

Emerson JI, Shi W, Paredes-Larios J, Walker WG, Hutton JE, Cristea IM, Marzluff WF, Conlon FL. Emerson JI, et al. Among authors: walker wg. Circ Res. 2024 Dec 30. doi: 10.1161/CIRCRESAHA.124.325447. Online ahead of print. Circ Res. 2024. PMID: 39772608

2

Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II.

Hunt SC, Cook NR, Oberman A, Cutler JA, Hennekens CH, Allender PS, Walker WG, Whelton PK, Williams RR. Hunt SC, et al. Among authors: walker wg. Hypertension. 1998 Sep;32(3):393-401. doi: 10.1161/01.hyp.32.3.393. Hypertension. 1998. PMID: 9740601 Clinical Trial.

3

Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis.

Karet FE, Gainza FJ, Györy AZ, Unwin RJ, Wrong O, Tanner MJ, Nayir A, Alpay H, Santos F, Hulton SA, Bakkaloglu A, Ozen S, Cunningham MJ, di Pietro A, Walker WG, Lifton RP. Karet FE, et al. Among authors: walker wg. Proc Natl Acad Sci U S A. 1998 May 26;95(11):6337-42. doi: 10.1073/pnas.95.11.6337. Proc Natl Acad Sci U S A. 1998. PMID: 9600966 Free PMC article.

4

At risk nephrons and the decline in renal function in response to treatment of hypertension.

Walker WG, Ford C. Walker WG, et al. Trans Am Clin Climatol Assoc. 1996;107:134-43; discussion 143-5. Trans Am Clin Climatol Assoc. 1996. PMID: 8725567 Free PMC article. Review.

5

Importance of blood pressure control in the preservation of renal function.

Walker WG. Walker WG. South Med J. 1994 Oct;87(10):1038-42. doi: 10.1097/00007611-199410000-00016. South Med J. 1994. PMID: 7939917 Review.

6

Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study.

Laidlaw SA, Berg RL, Kopple JD, Naito H, Walker WG, Walser M. Laidlaw SA, et al. Among authors: walker wg. Am J Kidney Dis. 1994 Apr;23(4):504-13. doi: 10.1016/s0272-6386(12)80371-4. Am J Kidney Dis. 1994. PMID: 8154485 Clinical Trial.

7

Hypertension-related renal injury: a major contributor to end-stage renal disease.

Walker WG. Walker WG. Am J Kidney Dis. 1993 Jul;22(1):164-73. doi: 10.1016/s0272-6386(12)70183-x. Am J Kidney Dis. 1993. PMID: 8322780 Free article. Review.

8

Relation of lipid abnormalities to progression of renal damage in essential hypertension, insulin-dependent and non insulin-dependent diabetes mellitus.

Walker WG. Walker WG. Miner Electrolyte Metab. 1993;19(3):137-43. Miner Electrolyte Metab. 1993. PMID: 8232100 Review.

9

Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group.

Walker WG, Neaton JD, Cutler JA, Neuwirth R, Cohen JD. Walker WG, et al. JAMA. 1992 Dec 2;268(21):3085-91. JAMA. 1992. PMID: 1433739 Clinical Trial.

10

Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group.

Levey AS, Gassman JJ, Hall PM, Walker WG. Levey AS, et al. Among authors: walker wg. J Am Soc Nephrol. 1991 Mar;1(9):1087-94. doi: 10.1681/ASN.V191087. J Am Soc Nephrol. 1991. PMID: 1912407 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters